Prescribing Information
Important Safety Information

Important Safety Information


INDICATION

TRUVADA FOR PrEP® (pre-exposure prophylaxis) is indicated to reduce the risk of sexually acquired HIV-1 in adults and adolescents (≥35 kg) who are at risk for HIV, when used in combination with safer sex practices. HIV-negative status must be confirmed immediately prior to initiation

Individuals at risk for sexually acquired HIV-1 may include those:

IMPORTANT SAFETY INFORMATION

BOXED WARNING: RISK OF DRUG RESISTANCE WITH USE OF TRUVADA FOR PrEP IN UNDIAGNOSED EARLY HIV-1 INFECTION and POST TREATMENT ACUTE EXACERBATION OF HEPATITIS B

Contraindications

Warnings and precautions: Comprehensive risk reduction strategies

Warnings and precautions

Adverse reactions

Drug interactions

Pregnancy and lactation

Dosage and administration